title: Olanzapine-induced hyperglycemia: role of humoral insulin resistance-inducing factors.
authors.forename: Markus
authors.initials: M
authors.lastname: Laimer
authors.forename: Christoph F
authors.initials: CF
authors.lastname: Ebenbichler
authors.forename: Michael
authors.initials: M
authors.lastname: Kranebitter
authors.forename: Ursula
authors.initials: U
authors.lastname: Eder
authors.forename: Barbara
authors.initials: B
authors.lastname: Mangweth
authors.forename: Elisabeth
authors.initials: E
authors.lastname: Weiss
authors.forename: Alex
authors.initials: A
authors.lastname: Hofer
authors.forename: Martina
authors.initials: M
authors.lastname: Hummer
authors.forename: Georg
authors.initials: G
authors.lastname: Kemmler
authors.forename: Monika
authors.initials: M
authors.lastname: Lechleitner
authors.forename: Josef R
authors.initials: JR
authors.lastname: Patsch
authors.forename: W Wolfgang
authors.initials: WW
authors.lastname: Fleischhacker
mesh_terms: D001569:Benzodiazepines / Q000009:adverse effects*; D006801:Humans; D006943:Hyperglycemia / Q000097:blood / Q000139:chemically induced* / Q000276:immunology; D007333:Insulin Resistance / Q000502:physiology*; D000077152:Olanzapine; D011446:Prospective Studies
chemical_list: D001569:Benzodiazepines; D000077152:Olanzapine